\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ provided\ \(5\)\
\-\ this\\ patient\\ was\\ treated\\ with\\ both\\ radiation\\ and\\ concomitant\\ chemotherapy\\.\ \(0\)\
\-\ t2\\ sequence\\ reveals\\ a\\ nasopharyngeal\\ mass\\ on\\ the\\ right\\ measuring\\ approximately\\ 2\\ cm\\.\\ it\\ invades\\ the\\ fossa\\ of\\ rosenmueller\\ and\\ there\\ is\\ extension\\ of\\ this\\ mass\\ into\\ the\\ skull\\ base\\.\\ it\\ is\\ heterogeneous\\ in\\ appearance\\ but\\ mildly\\ hyperintense\\ to\\ surrounding\\ muscles\\.\\ note\\ is\\ made\\ of\\ inflammatory\\ debris\\ within\\ the\\ right\\ mastoid\\ air\\ cells\\.\ \(0\)\
\-\ on\\ pre\\ contrast\\ t1\\ images\\,\\ the\\ mass\\ is\\ again\\ visualized\\.\\ it\\ is\\ isointense\\ to\\ the\\ surrounding\\ muscles\\.\\ after\\ administration\\ of\\ gd\\-dpta\\,\\ there\\ is\\ \\ homogeneous\\ enhancement\\ of\\ the\\ mass\\.\ \(0\)\
\-\ nasopharyngeal\\ carcinoma\\,\\ undifferentiated\\ type\\.\ \(0\)\
\-\ oropharyngeal\\ cancer\ \(2\)\
\-\ lymphoma\ \(373\)\
\-\ rhabdomyosarcoma\\ \\-\\ in\\ younger\\ patients\ \(0\)\
\-\ 34\\ y\\/o\\ male\\ with\\ hearing\\ difficulty\\ and\\ problems\\ swallowing\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nasopharyngeal\\:\\ 0\\.09404994708048148\ \(0\)\
\-\ gd\\-dpta\\:\\ 0\\.06996443193624205\ \(0\)\
\-\ muscles\\:\\ 0\\.06195021489254676\ \(0\)\
\-\ rosenmueller\\:\\ 0\\.06124528678808244\ \(0\)\
\-\ invades\\:\\ 0\\.05452070059453321\ \(0\)\
\-\ undifferentiated\\:\\ 0\\.05024295058871823\ \(0\)\
\-\ oropharyngeal\\:\\ 0\\.05024295058871823\ \(0\)\
\-\ it\\:\\ 0\\.0457344853460242\ \(0\)\
\-\ pre\\:\\ 0\\.044741782489036125\ \(0\)\
\-\ surrounding\\:\\ 0\\.04458992483118675\ \(0\)\
\-\ concomitant\\:\\ 0\\.04410652290432552\ \(0\)\
\-\ debris\\:\\ 0\\.041306353264462484\ \(0\)\
\-\ younger\\:\\ 0\\.03957838910696351\ \(0\)\
\-\ mastoid\\:\\ 0\\.039076969252824376\ \(0\)\
\-\ sequence\\:\\ 0\\.038454178654082356\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.03816020030741291\ \(0\)\
\-\ swallowing\\:\\ 0\\.03816020030741291\ \(0\)\
\-\ mass\\:\\ 0\\.037728920855478236\ \(0\)\
\-\ 34\\:\\ 0\\.03365720194811996\ \(0\)\
\-\ hearing\\:\\ 0\\.033415462206177825\ \(0\)\
\-\ isointense\\:\\ 0\\.03333649132639078\ \(0\)\
\-\ again\\:\\ 0\\.03258720811630289\ \(0\)\
\-\ homogeneous\\:\\ 0\\.032101855551593915\ \(0\)\
\-\ problems\\:\\ 0\\.03139449221908592\ \(0\)\
\-\ difficulty\\:\\ 0\\.030197485157700335\ \(0\)\
\-\ provided\\:\\ 0\\.02925095007177321\ \(0\)\
\-\ skull\\:\\ 0\\.02888387850311642\ \(0\)\
\-\ mildly\\:\\ 0\\.02888387850311642\ \(0\)\
\-\ hyperintense\\:\\ 0\\.028156033848437855\ \(0\)\
\-\ administration\\:\\ 0\\.028156033848437855\ \(0\)\
\-\ fossa\\:\\ 0\\.02764126691032642\ \(0\)\
\-\ visualized\\:\\ 0\\.02745184245471814\ \(0\)\
\-\ cells\\:\\ 0\\.027194021382142834\ \(0\)\
\-\ measuring\\:\\ 0\\.02712187081308528\ \(0\)\
\-\ made\\:\\ 0\\.027014860096122684\ \(0\)\
\-\ is\\:\\ 0\\.0267757513516536\ \(0\)\
\-\ base\\:\\ 0\\.02656712922882037\ \(0\)\
\-\ reveals\\:\\ 0\\.026533712303928755\ \(0\)\
\-\ note\\:\\ 0\\.026175123234141194\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.02493805679996036\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.024309093532864007\ \(0\)\
\-\ extension\\:\\ 0\\.024208946993505186\ \(0\)\
\-\ inflammatory\\:\\ 0\\.023518380509460503\ \(0\)\
\-\ air\\:\\ 0\\.02294652878215846\ \(0\)\
\-\ type\\:\\ 0\\.0228620970503723\ \(0\)\
\-\ cancer\\:\\ 0\\.022294962415593374\ \(0\)\
\-\ radiation\\:\\ 0\\.02225596229811378\ \(0\)\
\-\ t1\\:\\ 0\\.02149599631924003\ \(0\)\
\-\ approximately\\:\\ 0\\.020982681163139547\ \(0\)\
\-\ treated\\:\\ 0\\.020300403460983007\ \(0\)\
\-\ there\\:\\ 0\\.020185961213729977\ \(0\)\
\-\ appearance\\:\\ 0\\.019396083942338424\ \(0\)\
\-\ lymphoma\\:\\ 0\\.019382528844360997\ \(0\)\
\-\ carcinoma\\:\\ 0\\.019221648174729097\ \(0\)\
\-\ t2\\:\\ 0\\.019195148958336124\ \(0\)\
\-\ y\\/o\\:\\ 0\\.018782770077933653\ \(0\)\
\-\ cm\\:\\ 0\\.018190127919182425\ \(0\)\
\-\ enhancement\\:\\ 0\\.018178482270817746\ \(0\)\
\-\ patients\\:\\ 0\\.017552179360047823\ \(0\)\
\-\ both\\:\\ 0\\.017319047545127947\ \(0\)\
\-\ none\\:\\ 0\\.01682317068974608\ \(0\)\
\-\ into\\:\\ 0\\.016137510856823068\ \(0\)\
\-\ this\\:\\ 0\\.015256146243081477\ \(0\)\
\-\ contrast\\:\\ 0\\.01518075941911036\ \(0\)\
\-\ 2\\:\\ 0\\.01460400394055989\ \(0\)\
\-\ \\-\\:\\ 0\\.014537527450066376\ \(0\)\
\-\ but\\:\\ 0\\.014464311912964583\ \(0\)\
\-\ right\\:\\ 0\\.014311614430324074\ \(0\)\
\-\ after\\:\\ 0\\.01403175557626351\ \(0\)\
\-\ images\\:\\ 0\\.013010030888486936\ \(0\)\
\-\ within\\:\\ 0\\.012937550860206997\ \(0\)\
\-\ male\\:\\ 0\\.012263536014979945\ \(0\)\
\-\ on\\:\\ 0\\.011490333529609969\ \(0\)\
\-\ was\\:\\ 0\\.007843472398521324\ \(0\)\
\-\ the\\:\\ 0\\.0076805158168681\ \(0\)\
\-\ patient\\:\\ 0\\.006798348658066571\ \(0\)\
\-\ to\\:\\ 0\\.006778858864174384\ \(0\)\
\-\ in\\:\\ 0\\.006688844922861189\ \(0\)\
\-\ \\,\\:\\ 0\\.006445477750411604\ \(0\)\
\-\ of\\:\\ 0\\.004623166698332874\ \(0\)\
\-\ and\\:\\ 0\\.004285928707909963\ \(0\)\
\-\ a\\:\\ 0\\.0031476174747508035\ \(0\)\
\-\ \\.\\:\\ 0\\.002535681149810448\ \(0\)\
\-\ with\\:\\ 0\\.001857209144283964\ \(0\)\
